Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis
Kuan, Feng-Che, Kuo, Liang-Tseng, Chen, Min-Chi, Yang, Cheng-Ta, Shi, Chung-Sheng, Teng, David, Lee, Kuan-DerLanguage:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2015.356
Date:
October, 2015
File:
PDF, 985 KB
english, 2015